Position in LQDA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$12,914,346
+$9,895,146 QoQ
Shares Held
161,976
+102.5% QoQ
Ownership
0.181%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#52
of 334 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 51%
Shared 0%
None 49%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $455,921,156 across 48 Drug Manufacturers - Specialty & Generic names. LQDA ranks #9 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,437,213 | $103,278,126 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
120,078 | $65,061,862 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
312,832 | $52,724,705 | |
| 4 | VTRS |
Viatris Inc
|
2,872,464 | $45,614,728 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,264,159 | $31,110,952 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
633,778 | $21,973,083 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
197,060 | $21,861,836 | |
| 8 | ALKS |
Alkermes plc.
|
387,999 | $20,331,147 |
All Filings in LQDA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,914,346 | 161,976 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,019,200 | 80,000 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,707,085 | 78,489 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,077,117 | 91,342 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,142,444 | 91,689 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,260,579 | 85,463 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $948,467 | 80,652 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $779,110 | 77,911 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $961,968 | 80,164 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,051,571 | 71,293 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $846,081 | 70,331 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $449,582 | 70,912 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $560,199 | 71,363 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $469,423 | 67,934 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $403,552 | 63,352 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $349,634 | 64,271 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $261,770 | 60,039 | Shares | Sole | 2022-08-11 | |
| 2021-03-31 | $58,130 | 21,610 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $63,454 | 21,510 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $92,102 | 18,720 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $171,515 | 20,370 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $63,613 | 13,506 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||